OVA1 Next Generation
K150588 is the FDA 510(k) clearance record for OVA1 Next Generation, a class II device, cleared for Vermillion, Inc. on under FDA product code ONX (Ovarian Adnexal Mass Assessment Score Test System). FDA's definition for product code ONX reads: "An ovarian/adnexal mass assessment test is a devicem that measures one or more proteins in serum. It yields a single result for the likelihood that an adnexal pelvic mass in a woman, for whom surgery is planned, is malignant. The test isn...". FDA records list 2 510(k) clearances for Vermillion, Inc., from to . As of , FDA records show no recalls naming K150588.
Clearance record
- Decision date
- Received
- (375 days to decision)
- Product code
- ONX Ovarian Adnexal Mass Assessment Score Test System
- Regulation
- 21 CFR 866.6050
- Device class
- Class II
- Review panel
- Obstetrics/Gynecology
- Applicant
- Vermillion, Inc. 12117 Bee Caves Rd., Bldg. Iii, Suite 100, Austin TX
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code ONX
Trailing 12 monthsFDA records hold no clearances under product code ONX in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
